Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders

British Journal of Pharmacology(2021)10.1111/bph.15677Source: DataRank Database

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders is a research paper published in British Journal of Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 229 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access229 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 13.33)OA: bronzeTopics (52)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Morgane Thomsen ORCID,Gitta Wörtwein ORCID,Anders Fink‐Jensen ORCID,Mette Kruse Klausen ORCID

Live enrichment

PubMed:34532853 PMC:PMC8820218 OpenAlex:https://openalex.org/W3200755535

National Institute on Alcohol Abuse and Alcoholism

Grant: R01AA025071

National Institutes of Health

Grant: 2R01AA025071-04

Glucagon-like peptide-1 modulation of alcohol effects

FWCI

13.33

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Wiley Online Library User Agreement

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15677

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.15677

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15677

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1111/bph.15677

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15677

Fields of Study

Diabetes Treatment and ManagementRegulation of Appetite and ObesityNeuropeptides and Animal Physiology03 medical and health sciences0302 clinical medicine

MeSH Terms

Glucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsEthanolAnimalsDiabetes Mellitus, Type 2HumansBehavior, AddictiveGlucagon-Like Peptide 1

Keywords

Glucagon-like peptide-1GlucagonExenatideNeuroscienceEndocrinologyMedicineInternal medicineBioinformaticsChemistryBiologyDiabetes mellitusInsulinType 2 diabetesDopamineCocaineTobaccoAlcoholNicotineamphetamineOpioidsAddictionGlp-1Substance Use DisorderAlcohol Use DisorderFOOD-INTAKEWITHDRAWAL-INDUCED ANXIETYNUCLEUS-ACCUMBENSGlucagon-Like Peptide 1AnimalsHumansMESSENGER-RNASEXENDIN-4EthanolRECEPTOR AGONISTSCONCISE GUIDEVENTRAL TEGMENTAL AREABehavior, AddictiveDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor Agonists

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being